IRadimed Corp

IRMD

95.970USD

+1.430+1.51%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

IRadimed Corp's Score

Industry at a Glance

Industry Ranking

51 / 205

Overall Ranking

149 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

IRadimed Corp Highlights

StrengthsRisks

IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 37.41% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 73.24M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 73.24M.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 29.64%.

Overvalued

The company’s latest PE is 57.57, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 7.38M shares, decreasing 12.93% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 795.00 shares of this stock.

Analyst Rating

Based on 2 analysts

Buy

Current Rating

99.000

Target Price

+4.72%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of IRadimed Corp is 9.51, ranking 4 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 21.20M, representing a year-over-year increase of 15.69%, while its net profit experienced a year-over-year increase of 10.44%.

Score

Industry at a Glance

Previous score

9.51

Change

0



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

8.58

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

8.95

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of IRadimed Corp is 5.26, ranking 187 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 57.57, which is 8.25% below the recent high of 62.32 and 53.49% above the recent low of 26.78.

Score

Industry at a Glance

Previous score

5.26

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 51/205

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of IRadimed Corp is 8.00, ranking 60 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 99.00, with a high of 100.00 and a low of 98.00.

Score

Industry at a Glance

Previous score

8.00

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of IRadimed Corp is 6.93, ranking 75 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 102.82 and the support level at 91.22, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.71

Change

0.22

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of IRadimed Corp is 5.00, ranking 113 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 57.98%, representing a quarter-over-quarter decrease of 0.50%. The largest institutional shareholder is The Vanguard, holding a total of 558.41K shares, representing 4.39% of shares outstanding, with 0.96% increase in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Susi (Roger E)

4.59M

--

Nine Ten Capital Management LLC

771.38K

-11.54%

BlackRock Institutional Trust Company, N.A.

669.62K

+7.79%

The Vanguard Group, Inc.

Star Investors

564.87K

+0.98%

Renaissance Technologies LLC

Star Investors

488.76K

-0.62%

Copeland Capital Management, LLC

433.50K

-5.33%

Geode Capital Management, L.L.C.

266.34K

+1.89%

BlackRock Financial Management, Inc.

258.76K

-0.66%

Dimensional Fund Advisors, L.P.

214.55K

-0.41%

State Street Investment Management (US)

187.24K

+5.55%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of IRadimed Corp is 7.77, ranking 30 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.13. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

IRadimed Corp

IRMD

7.43 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.61 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Cencora Inc

COR

8.47 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Becton Dickinson and Co

BDX

8.46 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

AxoGen Inc

AXGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Align Technology Inc

ALGN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment